<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cyclooxyganase-2 (COX-2), a rate-limiting enzyme in the <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> synthesis pathway, is overexpressed in many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and contributes to <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> through <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell-autonomous and paracrine effects </plain></SENT>
<SENT sid="1" pm="."><plain>Regular use of <z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drugs</z:chebi> or selective COX-2 inhibitors (COXIBs) reduces the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development and progression, in particular of the colon </plain></SENT>
<SENT sid="2" pm="."><plain>The COXIB <z:chebi fb="0" ids="41423">celecoxib</z:chebi> is approved for adjunct therapy in patients with <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">Familial adenomatous polyposis</z:e> at high risk for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) formation </plain></SENT>
<SENT sid="3" pm="."><plain>Long-term use of COXIBs, however, is associated with potentially severe cardiovascular complications, which hampers their broader use as preventive anticancer agents </plain></SENT>
<SENT sid="4" pm="."><plain>In an effort to better understand the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressive mechanisms of COXIBs, we identified MAGUK with Inverted domain structure-1 (MAGI1), a scaffolding protein implicated in the stabilization of adherens junctions, as a gene upregulated by COXIB in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells and acting as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="5" pm="."><plain>Overexpression of MAGI1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines SW480 and HCT116 induced an epithelial-like <z:mp ids='MP_0000002'>morphology</z:mp>; stabilized E-cadherin and β-catenin localization at cell-cell junctions; enhanced actin stress fiber and focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> formation; increased cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to matrix proteins and suppressed Wnt signaling, anchorage-independent growth, migration and invasion in vitro </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, MAGI1 silencing decreased E-cadherin and β-catenin localization at cell-cell junctions; disrupted actin stress fiber and focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> formation; and enhanced Wnt signaling, anchorage-independent growth, migration and invasion in vitro </plain></SENT>
<SENT sid="7" pm="."><plain>MAGI1 overexpression suppressed SW480 and HCT116 subcutaneous <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> growth, attenuated <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> growth and spontaneous lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in an orthotopic model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and decreased the number and size of metastatic nodules in an experimental model of lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Collectively, these results identify MAG1 as a COXIB-induced inhibitor of the Wnt/β-catenin signaling pathway, with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressive and anti-metastatic activity in experimental <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>